Search Results

Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.

• Authors : Pau Parra A; Ramos N ...

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy; Adult ; Humans

• Source: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Jan-Feb; Vol. 48 (1), pp. 16-22. Date of Electronic Publisher: Elsevier España Country of Publication: Spain NLM ID: 9440679 Publication Model: Print-Electronic Cited Medium:

Record details

Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).

• Authors : Benítez Carabante MI; Division of Pediatric Hematology and Oncology, Hospital Universitari Vall d´Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.; Bueno D

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Thrombotic Microangiopathies*/Thrombotic Microangiopathies*/Thrombotic Microangiopathies*/drug therapy ; Thrombotic Microangiopathies*/Thrombotic Microangiopathies*/Thrombotic Microangiopathies*/etiology

• Source: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jun; Vol. 30 (6), pp. 601.e1-601.e13. Date of Electronic Publication: 2024 Mar 21.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

[Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.

• Authors : Parra AP; Ramos N ...

Subjects: Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/Atypical Hemolytic Uremic Syndrome*/drug therapy; Adult ; Humans

• Source: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Jan-Feb; Vol. 48 (1), pp. T16-T22. Date of Electronic Publisher: Elsevier España Country of Publication: Spain NLM ID: 9440679 Publication Model: Print-Electronic Cited Medium:

Record details

Researchers from Vall d'Hebron Hospital Describe Findings in Haemolytic Uraemic Syndrome (Eculizumab Discontinuation In Atypical Haemolytic Uraemic Syndrome: Tma Recurrence Risk and Renal Outcomes).

• Source: Health & Medicine Week. 2021, pages. 5385

Record details

[Paroxysmal nocturnal hemoglobinuria therapy with eculizumab: Spanish experience].

• Authors : López Rubio M; Servicio de Hematología y Hemoterapia, Hospital Universitario Príncipe de Asturias, Madrid, España. ; Morado M

Subjects: Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use ; Hemoglobinuria, Paroxysmal/Hemoglobinuria, Paroxysmal/Hemoglobinuria, Paroxysmal/*drug therapy; Adolescent

• Source: Medicina clinica [Med Clin (Barc)] 2011 Jun 11; Vol. 137 (1), pp. 8-13. Date of Electronic Publication: 2011 Feb 05.Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium:

Record details

Studies in the Area of Nephrology Reported from University Hospital (Eculizumab in dense-deposit disease after renal transplantation).

• Source: Health & Medicine Week. 2014, pages. 1148

Record details

Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.

• Authors : Villegas, Ana; Núñez, Ramiro; Gaya, Anna

Subjects: PAROXYSMAL hemoglobinuria; BLOOD diseases; ECULIZUMABSPAIN

• Source: Annals of Hematology; Oct2017, Vol. 96 Issue 10, p1727-1733, 7p

Record details

Meningococcal meningitis in Spain in the Horizon 2030: A position paper.

• Authors : Moraga-Llop, Fernando; Andradas, Elena; Blesa-Baviera, Luis Carlos

Subjects: MENINGOCOCCAL infections; NEISSERIA meningitidis; MENINGITISSPAIN

• Source: Revista Española de Quimioterapia; ago2024, Vol. 37 Issue 4, p285-298, 14p

Record details

Cross-sectional validation study of patient-reported outcomes in patients with paroxysmal nocturnal haemoglobinuria.

• Authors : Weitz, I.; Meyers, G.; Lamy, T.

Subjects: URINATION disorders; FATIGUE (Physiology); EVALUATION of medical careFRANCE; UNITED Kingdom; SPAIN

• Source: Internal Medicine Journal; Mar2013, Vol. 43 Issue 3, p298-307, 10p, 1 Chart, 4 Graphs

Record details

UCB is well-positioned to become a key player in the myasthenia gravis market with zilucoplan and rozanolixizumab, says GlobalData.

• Source: Chemical Business NewsBase (UK), May 19, 2022, 3pp

Record details